IOL Chemicals and Pharmaceuticals
IOL Chemicals and Pharmaceuticals Share Price Chart
IOL Chemicals and Pharmaceuticals last traded at ₹197.26 (2026-10-13). Over the past month the stock moved -6.6%, three months the stock moved +45.0%, year the stock moved +64.4%. Its closing range over 52 weeks is ₹68.90 – ₹220.40, with the latest close 10.5% below the high.
Closing prices up to 2026-10-13.
About IOL Chemicals and Pharmaceuticals
IOL Chemicals & Pharmaceuticals Ltd is a leading pharmaceutical (APIs) company and is a significant player in the specialty chemicals space. It serves the domestic and export market.[1]
Business Segment a) Pharmaceuticals Segment [1] Product Portfolio: Ibuprofen, Ibuprofen Lysinate, Ibuprofen Sodium, Dex-Ibuprofen, Metformin HCL, Paracetamol, Clopidogrel, Pantoprazole Sodium, Fenofibrate, Levetiracetam, Lamotrigine, Losartan Potassium
Fundamentals
Quarterly Results
In the latest quarter (Jun 2026), IOL Chemicals and Pharmaceuticals reported sales of ₹756.00 crore (+37.0%) and net profit of ₹64.00 crore (+88.2%), compared with the same quarter last year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Jun 2026 | 756.00 | 104.00 | 14.00 | 64.00 | 2.20 |
| Mar 2026 | 619.00 | 93.00 | 15.00 | 53.00 | 1.81 |
| Dec 2025 | 580.00 | 57.00 | 10.00 | 21.00 | 0.70 |
| Sep 2025 | 568.00 | 57.00 | 10.00 | 30.00 | 1.02 |
| Jun 2025 | 552.00 | 62.00 | 11.00 | 34.00 | 1.16 |
| Mar 2025 | 528.00 | 63.00 | 12.00 | 32.00 | 1.08 |
| Dec 2024 | 523.00 | 47.00 | 9.00 | 21.00 | 0.70 |
| Sep 2024 | 526.00 | 42.00 | 8.00 | 19.00 | 0.65 |
| Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|
| Sales growth | -3.5% | +0.6% | +4.8% | +10.0% | +8.0% | +10.9% | +17.2% | +37.0% |
| Operating profit growth | -34.4% | +6.8% | +26.0% | +21.6% | +35.7% | +21.3% | +47.6% | +67.7% |
| Net profit growth | -50.0% | -8.7% | +14.3% | +13.3% | +57.9% | +0.0% | +65.6% | +88.2% |
| EPS growth | -49.6% | -11.4% | +12.5% | +14.9% | +56.9% | +0.0% | +67.6% | +89.7% |
| OPM % | 8.0% | 9.0% | 12.0% | 11.0% | 10.0% | 10.0% | 15.0% | 14.0% |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
Annual Financials
In the latest year (Mar 2026), IOL Chemicals and Pharmaceuticals reported sales of ₹2,319.00 crore (+11.5%) and net profit of ₹138.00 crore (+36.6%), compared with the previous year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Mar 2026 | 2,319 | 269.00 | 12.00 | 138.00 | 4.69 |
| Mar 2025 | 2,079 | 202.00 | 10.00 | 101.00 | 3.44 |
| Mar 2024 | 2,133 | 232.00 | 11.00 | 135.00 | 4.61 |
| Mar 2023 | 2,217 | 227.00 | 10.00 | 140.00 | 4.77 |
| Mar 2022 | 2,184 | 257.00 | 12.00 | 166.00 | 5.64 |
| Mar 2021 | 1,967 | 592.00 | 30.00 | 445.00 | 15.15 |
| Mar 2020 | 1,894 | 574.00 | 30.00 | 361.00 | 12.70 |
| Mar 2019 | 1,685 | 410.00 | 24.00 | 237.00 | 8.32 |
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|
| Sales growth | +71.4% | +12.4% | +3.9% | +11.0% | +1.5% | -3.8% | -2.5% | +11.5% |
| Operating profit growth | +241.7% | +40.0% | +3.1% | -56.6% | -11.7% | +2.2% | -12.9% | +33.2% |
| Net profit growth | +746.4% | +52.3% | +23.3% | -62.7% | -15.7% | -3.6% | -25.2% | +36.6% |
| EPS growth | +740.4% | +52.6% | +19.3% | -62.8% | -15.4% | -3.4% | -25.4% | +36.3% |
| OPM % | 24.0% | 30.0% | 30.0% | 12.0% | 10.0% | 11.0% | 10.0% | 12.0% |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
Shareholding
AI Analysis
No AI analysis generated yet for IOL Chemicals and Pharmaceuticals.
Get Free AI Stock Analysis FREE →Latest News
-
IOL Chemicals & Pharmaceuticals consolidated net profit rises 89.80% in the June 2026 quarter - business-standard.com
-
NCLT sanctions J B Chemicals amalgamation with Torrent Pharmaceuticals - scanx.trade
-
NCLT sanctions J B Chemicals amalgamation with Torrent Pharmaceuticals - scanx.trade
-
NCLT sanctions amalgamation of J B Chemicals with Torrent Pharmaceuticals - scanx.trade
-
J B Chemicals & Pharmaceuticals Ltd gains for third consecutive session - Business Standard
-
IOL Chemicals & Pharmaceuticals consolidated net profit rises 69.19% in the March 2026 quarter - Business Standard
-
IOL Chemicals and Pharmaceuticals Board Meeting Scheduled on May 20, 2026 to Approve FY26 Financial Results - scanx.trade
-
J B Chemicals & Pharmaceuticals consolidated net profit declines 30.42% in the March 2026 quarter - Business Standard
-
IOL Chemicals and Pharmaceuticals Promoters Declare No Encumbrance on Shares for FY26 - scanx.trade
-
IOL Chemicals and Pharmaceuticals Promoters Declare No Encumbrance on Shares for FY26 - scanx.trade
Frequently Asked Questions
What is IOL Chemicals and Pharmaceuticals's current stock price?
IOL Chemicals and Pharmaceuticals shares were last quoted at ₹197.26 (-1.9% on the day). Use the Refresh price button on this page for the latest available price. Prices are for information only.
What is the P/E ratio of IOL Chemicals and Pharmaceuticals?
IOL Chemicals and Pharmaceuticals has a price-to-earnings (P/E) ratio of 35.65 and a price-to-book (P/B) ratio of 3.22. The industry P/E is 53.33.
What is the 52-week high and low of IOL Chemicals and Pharmaceuticals?
The 52-week high of IOL Chemicals and Pharmaceuticals is ₹219.05 and the 52-week low is ₹67.14.
What is the market cap of IOL Chemicals and Pharmaceuticals?
The market capitalisation of IOL Chemicals and Pharmaceuticals is about ₹5,995.30 crore.
How did IOL Chemicals and Pharmaceuticals perform in its latest quarterly results?
In the latest quarter (Jun 2026), IOL Chemicals and Pharmaceuticals reported sales of ₹756.00 crore (+37.0%) and net profit of ₹64.00 crore (+88.2%), compared with the same quarter last year.
Is IOL Chemicals and Pharmaceuticals a good stock to buy?
This page is for information and is not investment advice. As per the data shown here, IOL Chemicals and Pharmaceuticals has a 3-year ROE of 8.00%, 3-year profit growth of 2.00%. Review the fundamentals, quarterly results and AI analysis on StockSpin, and consult a SEBI-registered adviser before investing.
What is the promoter holding in IOL Chemicals and Pharmaceuticals?
Promoters hold about 62.28% of IOL Chemicals and Pharmaceuticals.
Which sector does IOL Chemicals and Pharmaceuticals belong to?
IOL Chemicals and Pharmaceuticals belongs to the Pharmaceuticals & Drugs sector.